1. Home
  2. FMST vs FEMY Comparison

FMST vs FEMY Comparison

Compare FMST & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foremost Lithium Resource & Technology Ltd. Common stock

FMST

Foremost Lithium Resource & Technology Ltd. Common stock

HOLD

Current Price

$3.06

Market Cap

27.5M

ML Signal

HOLD

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.90

Market Cap

30.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMST
FEMY
Founded
2005
2004
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.5M
30.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FMST
FEMY
Price
$3.06
$0.90
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.83
AVG Volume (30 Days)
247.7K
4.1M
Earning Date
11-13-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,061,502.00
Revenue This Year
N/A
$64.02
Revenue Next Year
N/A
$147.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
63.53
52 Week Low
$0.55
$0.31
52 Week High
$5.74
$1.80

Technical Indicators

Market Signals
Indicator
FMST
FEMY
Relative Strength Index (RSI) 56.89 55.49
Support Level $2.64 $0.83
Resistance Level $3.03 $1.03
Average True Range (ATR) 0.28 0.10
MACD 0.10 -0.01
Stochastic Oscillator 99.19 63.17

Price Performance

Historical Comparison
FMST
FEMY

About FMST Foremost Lithium Resource & Technology Ltd. Common stock

Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: